Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FGVD6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,424
Award facts
- Contract value 100% obligated
- $16,424.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $16,424.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Mirena 52 mg contraceptive systems. The delivery order, issued on January 22, 2026, with an ultimate completion date of February 12, 2026, carries no set-aside designation, indicating the contractor won this award through open competition. DMS Pharmaceutical Group Inc. will serve as the sole performer on this delivery order with no identified subcontractor involvement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors supplying pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The PPV-G GEN V contract awarded to DMS Pharmaceutical Group, valued at $499,999,999 and extending through December 31, 2036, authorizes the DLA to issue multiple delivery orders for branded and generic pharmaceuticals, biologics, vaccines, and medical supplies to support military healthcare operations globally. DMS Pharmaceutical Group's established performance on numerous prior delivery orders across diverse pharmaceutical categories demonstrates its capability to fulfill specialized medical supply requirements for federal military medical systems.
Quick answers
Who was awarded contract SPE2DR26FGVD6?
SPE2DR26FGVD6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FGVD6 worth?
The government has obligated $16,424 on SPE2DR26FGVD6.
Is contract SPE2DR26FGVD6 an order under another contract?
Yes. SPE2DR26FGVD6 is a delivery order under SPE2DR25D9761, an indefinite delivery contract.
Was contract SPE2DR26FGVD6 competed?
The extent of competition for SPE2DR26FGVD6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award